Dimension Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $15M

  • Investors
  • 24

Dimension Bio General Information

Description

Developer of a biotechnology platform designed to restore organ function lost to disease, trauma, or aging. The company offers a bioinspired cell delivery system combining materials science, 3D (Three-Dimensional) printing, and digital manufacturing, enabling patients with liver failure to receive supplemental liver support, helping the native liver recover, and providing an alternative to transplant.

Contact Information

Formerly Known As
Dimension Inx
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1375 West Fulton Street
  • Suite 500
  • Chicago, IL 60607
  • United States
+1 (312)
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Vertical(s)
Corporate Office
  • 1375 West Fulton Street
  • Suite 500
  • Chicago, IL 60607
  • United States
+1 (312)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dimension Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 30-Jan-2023 $15M Completed Generating Revenue
11. Grant 31-Dec-2021 Completed Generating Revenue
10. Seed Round 29-Nov-2021 Completed Generating Revenue
9. Grant 03-May-2021 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
7. Seed Round 18-Nov-2020 Completed Generating Revenue
6. Seed Round 30-Dec-2019 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
4. Seed Round 31-Aug-2017 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
To view Dimension Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Dimension Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biotechnology platform designed to restore organ function lost to disease, trauma, or aging. The company
Biotechnology
Chicago, IL
27 As of 2026

Newton, MA
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dimension Bio Competitors (4)

One of Dimension Bio’s 4 competitors is Satellite Bio, a Venture Capital-Backed company based in Newton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Satellite Bio Venture Capital-Backed Newton, MA
Aspect Biosystems Venture Capital-Backed Vancouver, Canada
Morphocell Technologies Venture Capital-Backed Laval, Canada
3D Systems Formerly VC-backed Rock Hill, SC
To view Dimension Bio’s complete competitors history, request access »

Dimension Bio Patents

Dimension Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026090489-A1 Coated particles for solvent-based inks Pending 25-Oct-2024
US-12139696-B2 Biointegrative implantable cell encapsulation device and system Active 19-Aug-2022
US-20240060028-A1 Biointegrative implantable cell encapsulation device and system Active 19-Aug-2022
WO-2024039773-A1 Biointegrative implantable cell encapsulation device and system Inactive 19-Aug-2022
AU-2022295672-A1 Method for fabrication of additively manufactured, self-gelling structures and their use Active 18-Jun-2021 B33Y80/00
To view Dimension Bio’s complete patent history, request access »

Dimension Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dimension Bio Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
10X Capital Venture Capital Minority
Alumni Ventures Venture Capital Minority
Calm Ventures Venture Capital Minority
Gaingels Venture Capital Minority
Hawktail Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Dimension Bio FAQs

  • When was Dimension Bio founded?

    Dimension Bio was founded in 2016.

  • Where is Dimension Bio headquartered?

    Dimension Bio is headquartered in Chicago, IL.

  • What is the size of Dimension Bio?

    Dimension Bio has 27 total employees.

  • What industry is Dimension Bio in?

    Dimension Bio’s primary industry is Biotechnology.

  • Is Dimension Bio a private or public company?

    Dimension Bio is a Private company.

  • What is Dimension Bio’s current revenue?

    The current revenue for Dimension Bio is .

  • How much funding has Dimension Bio raised over time?

    Dimension Bio has raised $20.5M.

  • Who are Dimension Bio’s investors?

    10X Capital, Alumni Ventures, Calm Ventures, Gaingels, and Hawktail are 5 of 24 investors who have invested in Dimension Bio.

  • Who are Dimension Bio’s competitors?

    Satellite Bio, Aspect Biosystems, Morphocell Technologies, and 3D Systems are competitors of Dimension Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process